Differential uptake of arginine derivatives by the human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1)
Дифференциальный захват производных аргинина гетеромеромного аминокислотного транспорта b0,+AT-rBAT (SLC7A9-SLC3A1)
2024-10-21
SCID: 54.1/z7ckqrep
Discuss with AI
IC50 inhibition of L-homoarginine by L-arginineL-arginine uptakeL-homoarginine uptakeMDCK double-transfected cellsapparent Km valuesasymmetric dimethylarginine (ADMA) transportb0,+AT-rBAT (SLC7A9-SLC3A1)renal proximal tubule luminal transporter
Figures from the paper
Abstract (AI)
Abstract L-arginine and its (patho-)physiologically active derivatives, L-homoarginine and asymmetric dimethylarginine (ADMA), show significant differences in their renal clearance. The underlying molecular mechanisms remain to be elucidated, but selective tubular transport protein-mediated mechanisms likely play a role. In the present study, we investigate the human heteromeric transporter b0,+AT-rBAT (encoded by the SLC7A9 and SLC3A1 genes) as a potential candidate because it is localized in the luminal membrane of human proximal tubule cells and capable of mediating the cellular uptake of amino acids, including L-arginine. Double-transfected Madin-Darby canine kidney (MDCK) cells stably expressing human b0,+AT-rBAT exhibited significant uptake of L-arginine and L-homoarginine, with apparent Km values of 512.6 and 197.0 μM, respectively. On the contrary, ADMA uptake was not saturated up to 4000 μM, with a transport rate > 5 nmol × mg protein−1 × min−1. With an IC50 value of 115.8 μM, L-arginine inhibited L-homoarginine uptake. Conversely, L-arginine only exhibited a partial inhibitory effect on ADMA uptake. Taken together, our data indicate that b0,+AT-rBAT may contribute to the differential renal handling of L-arginine, L-homoarginine, and ADMA.
Key Findings
1
ADMA uptake by b0,+AT-rBAT is not saturated up to 4000 μM and shows a transport rate >5 nmol·mg protein^-1·min^-1, indicating different transport characteristics from L-arginine and L-homoarginine.
2
Apparent Km values for uptake by b0,+AT-rBAT are 512.6 μM for L-arginine and 197.0 μM for L-homoarginine, indicating higher affinity for L-homoarginine.
3
Human heteromeric transporter b0,+AT-rBAT (SLC7A9-SLC3A1) mediates significant uptake of L-arginine and L-homoarginine in MDCK cells.
4
L-arginine inhibits L-homoarginine uptake with an IC50 of 115.8 μM, while only partially inhibiting ADMA uptake.
5
These results indicate b0,+AT-rBAT may contribute to the differential renal handling of L-arginine, L-homoarginine, and ADMA.
Research Object
Human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1)
Research Subject
Differential uptake kinetics and inhibitory interactions for L-arginine, L-homoarginine, and asymmetric dimethylarginine (ADMA) mediated by b0,+AT-rBAT, including Km, saturation behavior, transport rates and IC50-based inhibition
Publication Details
Publication Date
2024-10-21
Journal
Publisher
ISSN
Cited by
2
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest